Ethiopian world champion Gudaf Tsegay receives four-month doping ban

Gudaf Tsegay, a decorated Ethiopian athlete and former two-time world champion, has been handed a four-month doping ban. The ban follows her admission of the presence of a prohibited substance in an out-of-competition test conducted in December of the previous year. Tsegay, who secured the women's 5,000m world title in 2022 and the 10,000m crown in 2023, also won a bronze medal over 5,000m at the Tokyo 2020 Olympics.

The substance detected was a metabolite of Letrozole, which is listed by the World Anti-Doping Agency (WADA) as an aromatase inhibitor. Letrozole is medically used to lower estrogen levels, primarily in breast cancer treatment. Upon notification from the Athletics Integrity Unit (AIU) in late January, Tsegay explained that she had been prescribed Letrozole to treat a diagnosed medical condition, providing supporting medical documentation. She subsequently applied to World Athletics for a therapeutic use exemption (TUE), which was confirmed to meet WADA's international standards.

However, Tsegay's application for a retroactive TUE, citing exceptional circumstances, was ultimately rejected by WADA. She then entered into a case resolution agreement with WADA and the AIU. The AIU stated that a four-month ban was deemed "appropriate" under rules governing cases with no fault or negligence on the athlete's part. The duration of the sanction was influenced by Tsegay's degree of fault, her prompt admission of the violation, the fact that the substance's presence aligned with TUE standards, and the acknowledgment that she likely would have received a TUE if requested in advance.

Tsegay's period of ineligibility commenced retroactively on June 1 and will conclude on September 30. This ban means she will miss significant upcoming competitions. The ruling highlights the strict regulations in professional athletics regarding banned substances, even when athletes claim medical necessity.